Abstract
Purpose
The purpose of the study was to evaluate whether hematopoietic stem cell transplantation (HSCT) without conditioning Total Body Irradiation (TBI) had lower or milder ocular complication rates in the pediatric population.
Methods
This study included all children who underwent HSCT without conditioning TBI at the Chaim Sheba Medical Center between the years 2001 and 2008. All children had an ophthalmic evaluation prior to and every four months after HSCT.
Results
Of the 33 children who initially comprised this study, ten did not complete the minimal follow-up of four months, and were, thus, excluded from the study. Follow-up of the remaining 23 children ranged from four to 117 months. Dry eye related to chronic graft-versus-host disease (cGVHD) developed in eight children (35 %). In three cases, an additional complication was observed : corneal abscess, herpes zoster ophthalmicus, and bilateral subcapsular cataract (one case each). Posterior segment or neuro-ophthalmological complications were not observed in any patient.
Conclusion
In our study group, the preclusion of conditioning TBI before HSCT did not result in a decreased ocular complication rate compared to past publications, but complications were relatively mild and confined only to the anterior segment.
Similar content being viewed by others
References
Coskuncan NM, Jabs DA, Dunn JP, Haller JA, Green WR, Vogelsang GB, Santos GW (1994) The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol 112:372–379
Hirst LW, Jabs DA, Tutschka PJ, Green WR, Santos GW (1983) The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 101:580–584
Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813–1826
Uchino M, Ogawa Y, Uchino Y, Mori T, Okamoto S, Tsubota K (2012) Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation. Br J Ophthalmol 96:34–37
Slavin RE, Santos GW (1973) The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin Immunol Immunopathol 1:472–498
Riemens A, te Boome L, Imhof S, Kuball J, Rothova A (2010) Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol 21:485–494
Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW (1983) Ocular manifestations of graft-vs-host disease. Ophthalmology 90:4–13
Calissendorff B, el Azazi M, Lonnqvist B (1989) Dry eye syndrome in long-term follow-up of bone marrow transplanted patients. Bone Marrow Transplant 4:675–678
Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M, Ono M, Yang HY, Mashima Y, Oguchi Y, Ikeda Y, Tsubota K (1999) Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 83:1125–1130
Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:S19–S27
Balaram M, Rashid S, Dana R (2005) Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf 3:203–211
Pollack SM, O’Connor TP Jr, Hashash J, Tabbara IA (2009) Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review. Am J Clin Oncol 32:618–628
Bradfield YS, Kushner BJ, Gangnon RE (2005) Ocular complications after organ and bone marrow transplantation in children. J AAPOS 9:426–432
De Marco R, Dassio DA, Vittone P (1996) A retrospective study of ocular side effects in children undergoing bone marrow transplantation. Eur J Ophthalmol 6:436–439
Fahnehjelm KT, Tornquist AL, Olsson M, Winiarski J (2007) Visual outcome and cataract development after allogeneic stem-cell transplantation in children. Acta Ophthalmol Scand 85:724–733
Fahnehjelm KT, Tornquist AL, Winiarski J (2008) Dry-eye syndrome after allogeneic stem-cell transplantation in children. Acta Ophthalmol 86:253–258
Kalinina Ayuso V, Hettinga Y, van der Does P, Boelens JJ, Rothova A, de Boer J (2013) Ocular complications in children within 1 year after hematopoietic stem cell transplantation. JAMA Ophthalmol 131:470–475
Ng JS, Lam DS, Li CK, Chik KW, Cheng GP, Yuen PM, Tso MO (1999) Ocular complications of pediatric bone marrow transplantation. Ophthalmology 106:160–164
Suh DW, Ruttum MS, Stuckenschneider BJ, Mieler WF, Kivlin JD (1999) Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology 106:1564–1570
Calissendorff BM, Lonnqvist B, el Azazi M (1995) Cataract development in adult bone marrow transplant recipients. Acta Ophthalmol Scand 73:152–154
Deeg HJ, Flournoy N, Sullivan KM, Sheehan K, Buckner CD, Sanders JE, Storb R, Witherspoon RP, Thomas ED (1984) Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 10:957–964
Kerty E, Vigander K, Flage T, Brinch L (1999) Ocular findings in allogeneic stem cell transplantation without total body irradiation. Ophthalmology 106:1334–1338
Dunn JP, Jabs DA, Wingard J, Enger C, Vogelsang G, Santos G (1993) Bone marrow transplantation and cataract development. Arch Ophthalmol 111:1367–1373
Benyunes MC, Sullivan KM, Deeg HJ, Mori M, Meyer W, Fisher L, Bensinger R, Jack MK, Hicks J, Witherspoon R et al (1995) Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 32:661–670
Bernauer W, Gratwohl A, Keller A, Daicker B (1991) Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 115:925–930
Han SB, Yang HK, Hyon JY, Hwang JM (2013) Children with dry eye type conditions may report less severe symptoms than adult patients. Graefes Arch Clin Exp Ophthalmol 251:791–796
Lemp MA (1995) Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J 21:221–232
Schmid KE, Kornek GV, Scheithauer W, Binder S (2006) Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 51:19–40
Al-Tweigeri T, Nabholtz JM, Mackey JR (1996) Ocular toxicity and cancer chemotherapy. A review. Cancer 78:1359–1373
Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F, Al-Zahrani H, Mohammed SY, Nassar A, Aljurf M (2009) Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 116:1624–1629
Acknowledgments
This work was performed in partial fulfillment of the M.D. thesis requirements of Daniel Souroujon, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Michael Kinori, M.D, received support from a Talpiot Medical Leadership Program fellowship
Conflict of interest
All authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers’ bureaus, membership, employment, consultancies, stock ownership, or other equity interest, and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Michael Kinori and Bella Bielorai contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kinori, M., Bielorai, B., Souroujon, D. et al. Ocular complications in children after hematopoietic stem cell transplantation without total body irradiation. Graefes Arch Clin Exp Ophthalmol 253, 1397–1402 (2015). https://doi.org/10.1007/s00417-015-2964-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-015-2964-8